These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 19112915

  • 1. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
    Chen GH, Wu DP, Sun AN, Yang MZ, Wang Y, Tang XW, Chang HR, Feng YF, Zhu ZL.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
    [Abstract] [Full Text] [Related]

  • 2. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [Abstract] [Full Text] [Related]

  • 3. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ, Thompson JS, Jennings CD, Brown SA.
    Transplantation; 1995 Oct 27; 60(8):821-7. PubMed ID: 7482742
    [Abstract] [Full Text] [Related]

  • 4. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y, Wang HH, Wang M, Zhou Z, Zhai WJ, Huang Y, Jiang EL, Wang ZD, Zhou SY, Liu QG, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb 27; 27(2):82-6. PubMed ID: 16732957
    [Abstract] [Full Text] [Related]

  • 5. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y, Guo K, Chen Y, Song Z, Li J, Deng L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 27; 23(8):411-4. PubMed ID: 12411044
    [Abstract] [Full Text] [Related]

  • 6. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ.
    J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746
    [Abstract] [Full Text] [Related]

  • 7. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 May 01; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 8. [The action of donor-derived NK cell in leukemic mice MHC haplotype-mismatched bone marrow transplantation].
    Wang CY, Tan H, Guo KY.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb 01; 30(2):107-10. PubMed ID: 19563021
    [Abstract] [Full Text] [Related]

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 10. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L, Glass B, Zeis M, Dreger P, Steinmann J, Löffler H, Schmitz N.
    Exp Hematol; 1998 Feb 01; 26(2):93-9. PubMed ID: 9472798
    [Abstract] [Full Text] [Related]

  • 11. [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice].
    Wang SB, Guo KY, Hu DM, Yin B.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun 01; 26(6):810-3. PubMed ID: 16793606
    [Abstract] [Full Text] [Related]

  • 12. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH, Li DP, Zhang YJ, Zhang P, Zeng LY, Pan XY, Xu KL, Huang YH.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb 01; 33(2):88-93. PubMed ID: 22730654
    [Abstract] [Full Text] [Related]

  • 13. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
    Xu KL, Ju JP, Pan XY, Du B, Li ZY, Lu QX.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul 01; 24(7):372-5. PubMed ID: 12941194
    [Abstract] [Full Text] [Related]

  • 14. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B, Li DP, Xu KL, Pan XY.
    Chin Med J (Engl); 2005 Mar 20; 118(6):474-9. PubMed ID: 15788128
    [Abstract] [Full Text] [Related]

  • 15. [Experimental study on NK cells promoting donor marrow engraftment and hematopoietic reconstitution after MHC haploidentical BMT in mice].
    Wang CY, Guo KY, Wu BY, Wu LX, Jiang ZY, Pan XH.
    Zhonghua Xue Ye Xue Za Zhi; 2004 May 20; 25(5):290-2. PubMed ID: 15182539
    [Abstract] [Full Text] [Related]

  • 16. Suppression of graft-versus-host disease after adoptive infusion of alloreactive NK cells induced by silencing Ly49C gene in mice.
    Cao D, Hu L, Wang Y, Wang L, Zheng W, Ma W.
    Transpl Immunol; 2009 Mar 20; 20(4):243-8. PubMed ID: 19010415
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L, Reich S, Slavin S.
    Cytokines Cell Mol Ther; 1999 Sep 20; 5(3):145-52. PubMed ID: 10641572
    [Abstract] [Full Text] [Related]

  • 18. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M, Uharek L, Glass B, Gaska T, Gassmann W, Mueller-Ruchholtz W.
    Bone Marrow Transplant; 1994 Nov 20; 14(5):711-5. PubMed ID: 7889004
    [Abstract] [Full Text] [Related]

  • 19. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J, Gao L, Liu Y, Ren Y, Xie R, Fan H, Qian K.
    Transfusion; 2010 Feb 20; 50(2):407-17. PubMed ID: 19788510
    [Abstract] [Full Text] [Related]

  • 20. Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model.
    Uharek L, Glass B, Gaska T, Zeiss M, Gassmann W, Löffler H, Müller-Ruchholtz W.
    Bone Marrow Transplant; 1993 Feb 20; 12 Suppl 3():S57-60. PubMed ID: 8124260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.